Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4672440 | PMC |
http://dx.doi.org/10.3201/eid2112.141963 | DOI Listing |
Vet Res Commun
October 2024
Department of Clinical Analysis, School of Pharmacy, University of São Paulo, São Paulo, Brazil.
Jpn J Infect Dis
November 2024
Department of Clinical Infectious Diseases, Aichi Medical University Graduate School of Medicine, Japan.
The widespread prevalence of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli limits treatment options and is a worldwide problem. This study aimed to investigate the antimicrobial susceptibility and ESBL types of 204 strains of CTX-M-type ESBLsproducing E. coli isolated from 2011 to 2017 in the Chubu region of Japan and to identify factors correlated with susceptibility.
View Article and Find Full Text PDFAntibiotics (Basel)
April 2024
Institute of Medical Microbiology, Faculty of Medicine, Semmelweis University, 1089 Budapest, Hungary.
Extended-spectrum β-lactamase-producing ST131 has become widespread worldwide. This study aims to characterize the virulome, resistome, and population structure of ST131 isolates from clinical blood samples in Hungary. A total of 30 C2/H30Rx and 33 C1-M27 ST131 isolates were selected for Illumina MiSeq sequencing and 30 isolates for MinION sequencing, followed by hybrid de novo assembly.
View Article and Find Full Text PDFMicroorganisms
January 2024
Department of Biochemistry and Microbiology, University of Venda, Private Bag X5050, Thohoyandou 0950, South Africa.
The global spread of cefotaxime-hydrolysing β-lactamase (CTX-M)-producing () and its associated impact on paediatric diarrhoeal treatment and management has become a public health concern. This review assessed surveillance studies on CTX-M-producing associated with diarrhoea in children published between 2012 and 2022 globally. A total of thirty-eight studies were included for data analysis, categorised into continental regions, and tabulated.
View Article and Find Full Text PDFAntibiotics (Basel)
November 2023
Division of Bacterial Diseases, Bureau of Infectious Disease Diagnosis Control, Korea Disease Control and Prevention Agency, Cheongju-si 28159, Republic of Korea.
ESBL-producing is a public health concern in healthcare settings and the community. Between 2009 and 2018, a total of 187 ESBL-producing pathogenic isolates were identified, and clonal complex (CC) 10 was the predominant clone ( = 57). This study aimed to characterize the ESBL-producing pathogenic CC10 strains obtained from patients with diarrhea to improve our understanding of CC10 distribution in the Republic of Korea.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!